Expert forum
High-purity and label-free isolation of circulating tumor cells (CTCs) in a microfluidic platform by using optically-induced-dielectrophoretic (ODEP)
2017-12-08 07:41來源:原版作者:Huang SB
Negative selection-based circulating tumor cell (CTC) isolation is believed valuable to harvest more native, and in particular all possible CTCs without biases relevant to the properties of surface antigens on the CTCs. Under such a cell isolation strategy, however, the CTC purity is normally compromised. To address this issue, this study reports the integration of optically-induced-dielectrophoretic (ODEP) force-based cell manipulation, and a laminar flow regime in a microfluidic platform for the isolation of untreated, and highly pure CTCs after conventional negative selection-based CTC isolation. In the design, six sections of moving light-bar screens were continuously and simultaneously exerted in two parallel laminar flows to concurrently separate the cancer cells from the leukocytes based on their size difference and electric properties. The separated cell populations were further partitioned, delivered, and collected through the two flows. With this approach, the cancer cells can be isolated in a continuous, effective, and efficient manner. In this study, the operating conditions of ODEP for the manipulation of prostate cancer (PC-3) and human oral cancer (OEC-M1) cells, and leukocytes with minor cell aggregation phenomenon were first characterized. Moreover, performances of the proposed method for the isolation of cancer cells were experimentally investigated. The results showed that the presented CTC isolation scheme was able to isolate PC-3 cells or OEC-M1 cells from a leukocyte background with high recovery rate (PC-3 cells: 76-83%, OEC-M1 cells: 61-68%), and high purity (PC-3 cells: 74-82%, OEC-M1 cells: 64-66%) (set flow rate: 0.1 μl min(-1) and sample volume: 1 μl). The latter is beyond what is currently possible in the conventional CTC isolations. Moreover, the viability of isolated cancer cells was evaluated to be as high as 94 ± 2%, and 95 ± 3% for the PC-3, and OEC-M1 cells, respectively. Furthermore, the isolated cancer cells were also shown to preserve their proliferative capability. As a whole, this study has presented an ODEP-based microfluidic platform that is capable of isolating CTCs in a continuous, label-free, cell-friendly, and particularly highly pure manner. All these traits are found particularly meaningful for exploiting the harvested CTCs for the subsequent cell-based, or biochemical assays.
版權聲明:
本網(wǎng)站所有注明“來源:“陽普醫(yī)療”的文字、圖片和音視頻資料,版權均屬于陽普醫(yī)療所有,非經(jīng)授權,任何媒體、網(wǎng)站或個人不得轉(zhuǎn)載,授權轉(zhuǎn)載時須注明
“來源:陽普醫(yī)療”。本網(wǎng)所有轉(zhuǎn)載文章系出于傳遞更多信息之目的,且明確注明來源和作者,不希望被轉(zhuǎn)載的媒體或個人可與我們聯(lián)系,我們將立即進行刪除處理。
上一篇:Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.
返回首頁網(wǎng)友評論:
版主信息
昵稱:Mandy Luo
郵箱:mandyluo@improve-medical.com
相關閱讀
- > 《醫(yī)學拾萃》2023年12月刊:簡述實驗室信息管理系統(tǒng)發(fā)展歷程
- > 《醫(yī)學拾萃》2023年10月刊:分析前標本處理對神經(jīng)元特異性烯醇化酶(NSE)檢測的影響
- > 《醫(yī)學拾萃》2023年8月刊:PSA 檢測的標本處理、質(zhì)量控制及其臨床應用
- > 《醫(yī)學拾萃》2023年6月刊:真空采血管標本放置時間和溫度對常見檢驗項目的影響
- > 《醫(yī)學拾萃》2023年4月刊:游離 DNA 管使用現(xiàn)狀與展望
- > 《醫(yī)學拾萃》2023年2月刊:肝素管的臨床適用檢測項目與不適用項
- > 《醫(yī)學拾萃》2022年12月刊:血清分離技術及其對臨床生化檢驗結果的影響
- > 《醫(yī)學拾萃》2022年10月刊:標本處理對心肌肌鈣蛋白測定的影響
- > 《醫(yī)學拾萃》2022年8月刊:一種新型材料-水凝膠的合成及其應用
- > 《醫(yī)學拾萃》2022年6月刊:RFID 技術及其在醫(yī)療和標本管理中的應用與發(fā)展